
MDxHealth SA
MDXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974461940
- LEI:
- 549300J3MG9F9B5FY646
- Country:
- Belgium
- Address:
- Rue d'Abhooz 31, 4040 Herstal
- Website:
- https://mdxhealth.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies. Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2023-12-18 07:00 |
Delisting Announcement
MDXH PR EN.pdf
|
English | 241.9 KB | |
2023-12-18 07:00 |
Delisting Announcement
MDXH PR FR.pdf
|
French | 236.7 KB | |
2023-11-27 07:00 |
Delisting Announcement
PR 2023 10 27 EN.pdf
|
English | 249.4 KB | |
2023-11-27 07:00 |
Delisting Announcement
PR 2023 10 27 FR.pdf
|
French | 241.5 KB | |
2023-11-13 22:00 |
Share Issue/Capital Change
MDxHealth - New Denominator (EN).pdf
|
English | 249.5 KB | |
2023-11-13 22:00 |
Share Issue/Capital Change
MDxHealth - New Denominator (FR).pdf
|
French | 250.1 KB | |
2023-11-08 22:00 |
Earnings Release
MDxHealth 3Q23 FINAL EN.pdf
|
English | 288.9 KB | |
2023-11-08 22:00 |
Earnings Release
MDxHealth 3Q23 FINAL FR.pdf
|
French | 299.0 KB | |
2023-11-06 07:00 |
Post-Annual General Meeting Information
EGM results and process (FR).pdf
|
French | 261.5 KB | |
2023-11-06 07:00 |
Share Issue/Capital Change
EGM results and process (ENG).pdf
|
English | 259.2 KB | |
2023-11-06 07:00 |
Pre-Annual General Meeting Information
EGM Deed (3 November 2023).pdf
|
French | 4.3 MB | |
2023-11-06 07:00 |
Delisting Announcement
EGM results and process (ENG).pdf
|
English | 259.2 KB | |
2023-11-06 07:00 |
Post-Annual General Meeting Information
EGM results and process (FR).pdf
|
French | 261.5 KB | |
2023-10-20 22:00 |
Share Issue/Capital Change
MDxHealth - Press Release (ENG).pdf
|
English | 210.7 KB | |
2023-10-20 22:00 |
Share Issue/Capital Change
MDxHealth - Press Release (FR).pdf
|
French | 212.8 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-09-11 | KALFUS RON | Executive member | Buy | 400,000 | 116,000.00 EUR |
2023-09-10 | Sollee Joseph | Executive member | Buy | 200,000 | 58,000.00 EUR |
2022-09-26 | KALFUS RON | Executive member | Buy | 200,000 | 136,800.00 EUR |
2022-09-23 | Sollee Joseph | Executive member | Buy | 200,000 | 136,800.00 EUR |
2021-01-26 | SLAGMULDER REGINE | Board | Buy | 78,091 | 79,653.00 EUR |
2021-01-25 | SLAGMULDER REGINE | Board | Buy | 212,182 | 216,298.00 EUR |
2020-09-21 | SLAGMULDER REGINE | Board | Buy | 52,000 | 37,824.80 EUR |
2020-09-18 | SLAGMULDER REGINE | Board | Buy | 10,000 | 7,223.00 EUR |
2020-09-17 | SLAGMULDER REGINE | Board | Buy | 4,000 | 2,860.40 EUR |
2020-09-16 | SLAGMULDER REGINE | Board | Buy | 7,000 | 4,988.20 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |